BR100 Increased By (0.44%)
BR30 Increased By (1.39%)
KSE100 Increased By (0.62%)
KSE30 Increased By (0.61%)
BECO 5.43 Decreased By ▼ -0.06 (-1.09%)
BML 55.69 Decreased By ▼ -1.07 (-1.89%)
BOP 35.38 Increased By ▲ 0.26 (0.74%)
CNERGY 8.20 Increased By ▲ 0.05 (0.61%)
DCL 11.55 Increased By ▲ 0.04 (0.35%)
FCCL 58.36 Increased By ▲ 1.61 (2.84%)
FCSC 5.12 Decreased By ▼ -0.03 (-0.58%)
FFL 17.84 Decreased By ▼ -0.04 (-0.22%)
FNEL 1.25 No Change ▼ 0.00 (0%)
HUMNL 11.07 Decreased By ▼ -0.05 (-0.45%)
KEL 8.75 Increased By ▲ 0.33 (3.92%)
KOSM 6.69 Increased By ▲ 0.11 (1.67%)
MLCF 107.15 Increased By ▲ 3.85 (3.73%)
NBP 201.73 Increased By ▲ 1.55 (0.77%)
PACE 11.30 Increased By ▲ 0.01 (0.09%)
PAEL 44.49 Increased By ▲ 1.02 (2.35%)
PIAHCLA 29.41 Increased By ▲ 1.92 (6.98%)
PIBTL 18.64 Increased By ▲ 0.94 (5.31%)
PPL 247.98 Increased By ▲ 3.66 (1.5%)
PRL 35.29 Decreased By ▼ -0.14 (-0.4%)
PTC 66.14 Increased By ▲ 0.79 (1.21%)
SEARL 95.49 Increased By ▲ 2.17 (2.33%)
SSGC 32.04 Decreased By ▼ -0.90 (-2.73%)
TELE 8.87 Decreased By ▼ -0.04 (-0.45%)
THCCL 66.61 Decreased By ▼ -0.11 (-0.16%)
TPLP 10.57 Decreased By ▼ -0.26 (-2.4%)
TREET 25.30 Increased By ▲ 0.18 (0.72%)
TRG 64.40 Decreased By ▼ -0.50 (-0.77%)
WAVES 10.90 Decreased By ▼ -0.03 (-0.27%)
WTL 1.26 Increased By ▲ 0.01 (0.8%)
Markets

European shares muted at end of stellar month; eyes on Brexit

  • London's blue-chip stocks outperformed regional peers to trade up 0.2pc as healthcare and industrial shares gained.
Published November 30, 2020 Updated November 30, 2020 03:47pm
By

Europe's benchmark stock index was flat on Monday with focus on Brexit negotiations, but was still on track for its best month on record on the prospect of easing coronavirus restrictions and hopes for a COVID-19 vaccine.

After face-to-face talks restarted on Saturday, investors await news of a call between UK Prime Minister Boris Johnson and EU Commission president Ursula von der Leyen, seen as the first sign of movement either towards a trade deal or of talks crumbling five weeks ahead of the deadline.

London's blue-chip stocks outperformed regional peers to trade up 0.2pc as healthcare and industrial shares gained.

While upbeat factory activity data from China kept alive hopes of a global economic recovery, it did little to buoy the pan-European STOXX 600 index after its near 15pc surge so far in November.

Gains have been driven by promising trial results for major coronavirus vaccine candidates, and hopes of a more stable U.S. trade policy after Joe Biden's victory in the U.S. presidential elections.

France's CAC 40 has jumped almost 22pc this month, while Spain's IBEX and Italy's MIB gained around 25pc each. German shares and UK blue-chips have gained more than 14pc.

"The markets have moved so aggressively this month, and there isn't anything really there to cause any further significant rally," said Connor Campbell, a financial analyst at Spreadex.

Oil and gas stocks were the biggest decliners in Europe, down 1.7pc, with Total SE, BP and Royal Dutch Shell sliding as crude prices fell ahead of a meeting of producer group OPEC+ to decide whether to extend large output cuts.

At the bottom of the STOXX 600 was Dutch bank ABN Amro, down 4.7pc after saying it would cut almost 3,000 jobs by 2024.

The economic outlook brightened as slowing COVID-19 infection rates in many European countries encouraged governments to lift some curbs - Britain is due to return to a regional approach to restrictions from Dec. 2, while Ireland will allow shops, restaurants, gyms and pubs serving food to reopen next week.

However, the number of coronavirus cases in Germany remained high, with economic institute Ifo saying a partial lockdown saw the share of companies using short-time work schemes rising in November from the previous month.

Comments

Comments are closed for this article.